0
uniQure N.V. Banner Image

uniQure N.V.

  • Ticker QURE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
uniQure N.V. Logo Image
  • 201-500 Employees
  • Based in Amsterdam, Netherlands
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. They are leveraging their modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.
REPORT RATINGS
5.0 / 5.0 (1)

uniQure N.V. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

uniQure N.V.

Most Recent Responsibility Report

uniQure N.V.
MOST RECENT 2022 Corporate Responsibility Report

uniQure N.V. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived uniQure N.V. Sustainability Report, uniQure N.V. Corporate Social Responsibility Report, uniQure N.V. CSR Report, uniQure N.V. Corporate Responsibility, uniQure N.V. CR Report, uniQure N.V. Citizenship Report, uniQure N.V. ESG Report, and uniQure N.V. Environmental Report online.
uniQure N.V. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!